University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer ...

Emerging treatments for low-grade serous ovarian cancer and platinum-resistant disease offer new hope, with promising data ...

综述：细胞焦亡（Pyroptosis）与紫杉醇（Paclitaxel）在抗肿瘤作用中的治疗联系：最新综述 《Naunyn-Schmiedeberg's Archives of Pharmacology》：Therapeutic connections between pyroptosis and paclitaxel in anti-tumor effects: an updated review ...

Conclusions: BBI608 plus weekly paclitaxel has demonstrated safety, tolerability, and promising activity in patients with refractory, heavily pretreated pancreatic cancer; particularly in taxane-naïve ...

Background: Gynecologic carcinosarcomas (CS) are rare yet aggressive epithelial malignancies for which optimal therapy is debated. PI was shown to be superior to I. PC demonstrated compelling phase 2 ...

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...

The addition of carboplatin to paclitaxel improved pathologic complete response and EFS with no increase in secondary malignancies among patients with triple-negative breast cancer, randomized ...

There was a 16% greater hazard of death (HR, 1.16; 95% CI, 1.05-1.29) following receipt of paclitaxel for every year on treatment before receiving the taxane therapy.

Paclitaxel Medication Information Learn everything you need to know about Paclitaxel-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information ...

In this press release, forward-looking statements include statements concerning: our ROSELLA trial and the potential of relacorilant combined with nab-paclitaxel to benefit patients; our BELLA ...